Skip to main content
OpenTrials
Completed

NCT Number: NCT07500155

Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery

This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intracranial Aneurysm AV Fistula AVM - Cerebral Arteriovenous Malformation Acute Ischemic Stroke Aneurysm Arteriovenous Fistula Arteriovenous Malformations Brain Diseases Cardiovascular Abnormalities Cardiovascular Diseases Central Nervous System Diseases Central Nervous System Vascular Malformations Cerebrovascular Disorders Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Extracranial Atherosclerosis Fistula Intracranial Arterial Diseases Intracranial Arteriovenous Malformations Ischemic Stroke Nervous System Diseases Nervous System Malformations Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Stroke Vascular Diseases Vascular Fistula Vascular Malformations

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Xingtai central hospital

Xingtai, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Undertaken a neurovascular surgery procedure including Tarvos microguidewire
  • Available images of Tarvos Microguidewire in the neurovascular surgery.

Exclusion criteria

  • Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome)
  • Prior vascular dissection or injury to the target vessels
  • Not meeting the data requirements needed for this study.

Treatment and study plan

Tarvos Microguidewire

Device

This product is indicated for use in neurovascular interventions to assist in the delivery of diagnostic or therapeutic devices to the target lesion site.

Primary outcomes

  1. Device success rate

    Time frame: during surgery

    Number of patients with device success / Number of recruited patients* 100%

Secondary outcomes

  1. Ability to assist in the delivery of other interventional devices to the targeted vessel position.

    Time frame: during surgery

Other outcomes

  1. Incidence of adverse events, serious adverse events and device deficiencies

    Time frame: within postoperative 24 hrs

Sponsors and collaborators

Lead sponsor

Keuro MedTech

Industry

Registry information

Official study title

Evaluation of Clinical Effectiveness and Safety of Tarvos Microguidewire in Neurovascular Interventional Surgery

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Mar 30, 2026
Registry last updated
Apr 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.